Related Experiment Video
Updated: Jan 7, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Transcatheter Aortic Valve Replacement for Aortic Regurgitation: A Case-Based Review
Lucas Uchoa de Assis1, Andrea Mariani2, Antigone Kostea1
1Department of Cardiology, Thoraxcenter, Cardiovascular Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Insights
Transcatheter aortic valve replacement (TAVR) offers a less invasive option for aortic regurgitation (AR) when surgery is high-risk. Dedicated devices show promise, but further research and device improvements are needed for wider TAVR adoption in AR treatment.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Aortic regurgitation (AR) is a common valvular heart disease, increasing with age.
- Surgical aortic valve replacement is standard but often deferred due to high surgical risk, leaving many severe AR patients untreated.
- Transcatheter aortic valve replacement (TAVR) is a less invasive alternative, but off-label use faces challenges.
Purpose of the Study:
- To review the evolving role of TAVR in treating aortic regurgitation.
- To highlight practical considerations for TAVR in AR using patient vignettes.
- To discuss device selection, anchoring, and complication management in TAVR for AR.
Main Methods:
- Case-based review utilizing three patient vignettes.
- Discussion of device selection and anchoring strategies for TAVR in AR.
- Exploration of complication management in TAVR for AR.
Main Results:
- Dedicated TAVR devices have improved procedural success for AR by addressing anchoring difficulties.
- Patient vignettes illustrate key considerations in TAVR for AR.
- Outcomes with dedicated TAVR systems for AR are encouraging.
Conclusions:
- TAVR is an evolving treatment option for aortic regurgitation, particularly in high-risk patients.
- Dedicated TAVR devices demonstrate improved efficacy and safety for AR.
- Further research and device innovation are necessary to establish TAVR as a standard treatment for AR and improve patient outcomes.
Abstract:
Aortic regurgitation (AR) is the third most common valvular heart disease and its prevalence increases with age. Surgical aortic valve replacement remains the standard treatment but is often deferred due to perceived high surgical risk and frailty, leaving nearly one‑third of patients with severe AR untreated. Transcatheter aortic valve replacement (TAVR) offers a less invasive alternative, but off-label use of transcatheter valves designed for aortic stenosis has been limited by anchoring difficulties, valve embolization, and residual regurgitation. Dedicated devices have addressed these challenges with tailored anchoring mechanisms and demonstrated improved procedural success. This case-based review explores the evolving role of TAVR for AR through 3 patient vignettes that highlight practical considerations for device selection, anchoring strategies, and complication management. While outcomes with dedicated systems are encouraging, further research should establish TAVR in AR treatment. In parallel, device iterations are required to curtail procedure-induced conduction disturbances and broaden anatomical eligibility.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction